Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 3.18% is 119% above its 5-year average of -17.13%, near the high end of its 5-year range (-30.95%–3.18%).
138.69% above its 12-month average of -8.22%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 2.86%.
RETURN ON ASSETS (ROA)
3.18%
RETURN ON ASSETS (ROA) AVG TTM
-8.22%
RETURN ON ASSETS (ROA) AVG 3Y
-16.26%
RETURN ON ASSETS (ROA) AVG 5Y
-17.13%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+138.69%
CURRENT VS 3Y AVG
+119.56%
CURRENT VS 5Y AVG
+118.57%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-26.34%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
+112.07%
vs the sector median at left
Alignment Healthcare, Inc.
Market Cap
$1.76B
Return on Assets (ROA)
3.18%
TTM Avg
-8.22%
3Y Avg
-16.26%
5Y Avg
-17.13%
Market Cap
$1.78B
Return on Assets (ROA)
-46.66%
TTM Avg
-46.30%
3Y Avg
-40.19%
5Y Avg
-33.55%
Market Cap
$1.78B
Return on Assets (ROA)
-61.53%
TTM Avg
-47.53%
3Y Avg
-47.53%
5Y Avg
-47.53%
Market Cap
$1.71B
Return on Assets (ROA)
-10.49%
TTM Avg
-13.41%
3Y Avg
-10.26%
5Y Avg
-6.23%
Market Cap
$1.83B
Return on Assets (ROA)
1.78%
TTM Avg
2.10%
3Y Avg
3.84%
5Y Avg
3.40%
Market Cap
$1.66B
Return on Assets (ROA)
-43.15%
TTM Avg
-37.60%
3Y Avg
-124.49%
5Y Avg
-99.59%
Market Cap
$1.87B
Return on Assets (ROA)
-37.11%
TTM Avg
4.34%
3Y Avg
-11.90%
5Y Avg
4.27%
Market Cap
$1.65B
Return on Assets (ROA)
7.08%
TTM Avg
2.00%
3Y Avg
-0.05%
5Y Avg
-1.77%
Market Cap
$1.65B
Return on Assets (ROA)
-13.91%
TTM Avg
-19.51%
3Y Avg
-22.81%
5Y Avg
-24.34%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alignment Healthcare, Inc. (ALHC) | $1.76B | 3.18% | -8.22% | -16.26% | -17.13% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | -46.66% | -46.30% | -40.19% | -33.55% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | -61.53% | -47.53% | -47.53% | -47.53% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | -10.49% | -13.41% | -10.26% | -6.23% |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 1.78% | 2.10% | 3.84% | 3.40% |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.66B | -43.15% | -37.60% | -124.49% | -99.59% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.87B | -37.11% | 4.34% | -11.90% | 4.27% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 7.08% | 2.00% | -0.05% | -1.77% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | -13.91% | -19.51% | -22.81% | -24.34% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 11.27% | -4.02% | -13.89% | -9.34% |
ROA
3.2%
ROE
15.3%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -0.07% |
| 2024-12-31 | -16.37% |
| 2023-12-31 | -25.01% |
| 2022-12-31 | -23.59% |
| 2021-12-31 | -30.95% |
| 2020-12-31 | -6.77% |
| 2019-12-31 | -23.12% |
